New Key Statistics Module, Z-Score and F-Score
NAS:HALO Key Ratios
Market Cap $ M | 5,796.06 |
Enterprise Value $ M | 6,760.94 |
P/E(ttm) | 18.82 |
PE Ratio without NRI | 18.40 |
Forward PE Ratio | 15.15 |
Price/Book | 32.53 |
Price/Sales | 6.98 |
Price/Free Cash Flow | 14.16 |
Price/Owner Earnings | 14.69 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 862.00 |
EPS (TTM) $ | 2.42 |
Beneish M-Score | -2.84 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | 65.90 |
EV-to-EBIT | 16.46 |
EV-to-EBITDA | 13.65 |
PEG | -- |
Shares Outstanding M | 127.27 |
Net Margin (%) | 36.94 |
Operating Margin % | 43.95 |
Pre-tax Margin (%) | 45.44 |
Quick Ratio | 5.36 |
Current Ratio | 6.64 |
ROA % (ttm) | 17.76 |
ROE % (ttm) | 219.05 |
ROIC % (ttm) | 23.69 |
Dividend Yield % | -- |
Altman Z-Score | 3.88 |
HALO Number of Guru Trades
HALO Volume of Guru Trades
Gurus Latest Trades with NAS:HALO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:HALO is held by these investors
Total 2
Halozyme Therapeutics Inc Insider Transactions
No Available Data
News about NAS:HALO
Total 0- 1